Intraday MarketsStock report · INSM · Insmed Incorporated · Nov 2, 2026
Intraday Markets
Home › Stocks › INSM

INSM Stock: Price, Earnings History and SEC Filings

Insmed Incorporated (INSM) last traded at $112.58, up 0.89% on the latest session and down 1.4% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $-0.46 against an analyst estimate of $-0.34, a miss of 35.3%.

$112.58 +0.89%
1 month-1.37%
52-week high$212.75
52-week low$90.39
Volume5.18M
ExchangeNasdaqGS

Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.

INSM earnings history

QuarterReportedEPSEstimateSurprise
Sep 2026Oct 29, 2026$-0.46$-0.34-35.29%
Jun 2026Aug 6, 2026$-0.52$-0.69+24.64%
Mar 2026May 7, 2026$-0.76$-0.90+15.56%
Dec 2025Feb 19, 2026$-1.54$-1.07-43.93%

INSM beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.

How INSM reacts to earnings

Across its last 8 earnings releases, INSM moved 12.6% on average the next session, in either direction. It rose after 4 of 8 reports.

Report dateReleasedNext-session move
2026-10-29Before open+15.06%
2026-08-06Before open+33.86%
2026-05-07Before open-23.41%
2026-02-19Before open+6.54%
2025-10-30Before open+16.33%
2025-08-07Before open-1.76%
2025-05-08Before open-3.88%
2025-02-20Before open-0.26%

Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.

INSM financial history

Revenue
$10M2018$136M2019$164M2020$188M2021$245M2022$305M2023$364M2024$606M2025
Net income
-$324M2018-$254M2019-$294M2020-$435M2021-$482M2022-$750M2023-$914M2024-$1.3B2025
Free cash flow
-$271M2018-$293M2019-$226M2020-$371M2021-$410M2022-$550M2023-$706M2024-$968M2025
Fiscal yearRevenueNet incomeFree cash flowNet marginDiluted EPS
2025$606M-$1.3B-$968M-210.5%$-6.42
2024$364M-$914M-$706M-251.2%$-5.57
2023$305M-$750M-$550M-245.6%$-5.34
2022$245M-$482M-$410M-196.3%$-3.91
2021$188M-$435M-$371M-230.6%$-3.88
2020$164M-$294M-$226M-178.9%$-3.01
2019$136M-$254M-$293M-186.4%$-3.01
2018$10M-$324M-$271M-3297.2%–

Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.

Latest SEC filings for INSM

Insider filing activity

INSM insiders filed 6 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.

Source: SEC EDGAR.

INSM news

About Insmed Incorporated

Insmed Incorporated (INSM) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in VA. Its fiscal year ends in December.

Open the live terminal

Related stocks

NVDAAAPLMSFTGOOGLAMZNMETATSLAAVGOAll stocks
intradaymarkets.com · Information only, not investment advice · Data from public sources and may be delayed